Vanguard Group Inc Generation Bio Co. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Vanguard Group Inc holds 2,298,347 shares of GBIO stock, worth $9.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,298,347
Previous 2,619,709
12.27%
Holding current value
$9.31 Million
Previous $1.05 Million
29.8%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding GBIO
# of Institutions
60Shares Held
41.5MCall Options Held
116KPut Options Held
0-
Price T Rowe Associates Inc Baltimore, MD8.46MShares$34.3 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$33.5 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$13.3 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.97MShares$12 Million0.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.58MShares$10.5 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $239M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...